Sensors for Medicine and Science Inc.
Executive Summary
Sensors for Medicine and Science Inc. is developing a miniature biosensor that can be inserted under a patient's skin to continuously monitor glucose or other anayltes.
You may also be interested in...
A Decade of Development for SMSI: Will it lead to Improved Accuracy in CGM?
The mission of ten-year old company Sensors for Medicine & Science is to develop a sensor that would obviate the need for patients with diabetes to extract blood or fluid samples for testing. Implanted under the skin, the SMSI sensor is continuously immersed in interstitial fluid containing glucose and provides frequent glucose readings. It thus has the potential to become the cornerstone of a new continuous glucose monitoring (CGM) system, one that works very differently than the early-generation systems on the market today. Part of a group of articles that includes: "Where are They Now? Checking in on Three Glucose Monitoring Companies," "Pelikan Swoops in on the Big Four" and "GlucoLight: Making Non-Invasive Glucose Monitoring Real."
Where are They Now? Checking in on Three Glucose-Monitoring Start-Ups
Laying out a strategy is one thing; executing it is another. That's why, from time to time, START-UP revisits companies it has written about in the past to find out what went according to plan, and what didn't. As we revisit the field of glucose monitoring--a field with a high attrition rate, we'll see if we can draw out some lessons, both from the successes and from the failures, for those starting out today. (Introduction to three separate articles in the December 2007 issue: "Pelikan Technologies Swoops in on the Big Four"; "A Decade of Development for SMSI: Will It Yield Improved Accuracy in CGM?" and "GlucoLight Makes Non-invasive Glucose Monitoring Real.")
A Decade of Development for SMSI: Will it lead to Improved Accuracy in CGM?
The mission of ten-year old company Sensors for Medicine & Science is to develop a sensor that would obviate the need for patients with diabetes to extract blood or fluid samples for testing. Implanted under the skin, the SMSI sensor is continuously immersed in interstitial fluid containing glucose and provides frequent glucose readings. It thus has the potential to become the cornerstone of a new continuous glucose monitoring (CGM) system, one that works very differently than the early-generation systems on the market today. Part of a group of articles that includes: "Where are They Now? Checking in on Three Glucose Monitoring Companies," "Pelikan Swoops in on the Big Four" and "GlucoLight: Making Non-Invasive Glucose Monitoring Real."